KADIMA IN THE NEWS
Kadima and Dr. Feifel’s groundbreaking work on Ketamine and TMS therapy has garnered the attention of major news outlets such as The New York Times, TIME Magazine, The Washington Post, NPR, Popular Science, NBC, Scientific American, and USA Today, among others.
“Barbara Reiger, who’s 59 and lives in San Diego, says she tried nearly everything to lift her out of the depression that had plagued her since childhood and sometimes rendered her suicidal.When she learned about ketamine in 2015, she decided to try it at a ketamine clinic in her hometown. Since ketamine is FDA-approved as an anesthetic, physicians can legally prescribe it off-label for any condition they believe it may help, including depression.Ketamine trips are known to help people disconnect from their bodies and their thoughts, and it worked that way for Reiger. After her first trip, she remembers feeling better than she had for years. “I immediately felt relief … a lightness of the depression kind of lifting,” says Reiger. And it all happened in less than an hour.”
Read the full story on Time Magazine
In an interview with Dr. Sanjay Gupta on CNN’s Chasing Life podcast, Dr. David Feifel, a leading expert in ketamine therapy and founder of Kadima Neuropsychiatry, discussed the rising use of ketamine in mental health treatment. He addressed both the promise and the challenges surrounding ketamine, especially following the tragic death of actor Matthew Perry, who was using ketamine for depression without medical supervision before his passing.
Read the full story on CNN
In this CNN flash documentary Dr. Sanjay Gupta, Dr. Carl Hart, Dr. David Feifel and other experts discuss ketamine therapy. The program draws a crucial distinction between ketamine’s dangerous recreational use and its groundbreaking therapeutic potential in mental health treatment. Through clinical evidence and expert testimony, the documentary highlights how ketamine, when administered in controlled medical settings, has emerged as a revolutionary tool for treating conditions like depression and PTSD.
ABC10 San Diego recently featured Kadima Neuropsychiatry Institute and Dr. Feifel in a special segment highlighting our groundbreaking psychedelic clinical trials, including ongoing research on LSD for Anxiety.
The story followed one of our study participants, highlighting their positive experience and offering a glimpse into the care and structure behind how these studies are conducted.
Kadima and Dr. Feifel featured in the news (click for full article)
Kadima featured on broadcasted news
Playlist
2:53
2:29
2:11
4:05
28:00
4:12
Leave your details and we will contact you:
Your information is kept secure and will not be sold to third parties. Click here to read our Privacy Policy